Andrew B. Benowitz

1.8k total citations
22 papers, 714 citations indexed

About

Andrew B. Benowitz is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Andrew B. Benowitz has authored 22 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Hematology and 3 papers in Organic Chemistry. Recurrent topics in Andrew B. Benowitz's work include Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Andrew B. Benowitz is often cited by papers focused on Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Andrew B. Benowitz collaborates with scholars based in United States, United Kingdom and Ireland. Andrew B. Benowitz's co-authors include Steve Fidanze, Yoshito Kishi, John D. Harling, Fengbin Song, Markus A. Queisser, Pamela L. C. Small, Han Dai, Katherine L. Jones, Jenni Cryan and Melanie Schneider and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Andrew B. Benowitz

21 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew B. Benowitz United States 13 509 207 187 98 83 22 714
Jörg Trappe Switzerland 14 463 0.9× 180 0.9× 153 0.8× 105 1.1× 53 0.6× 15 831
Benjamin P. Martin United States 15 716 1.4× 269 1.3× 109 0.6× 204 2.1× 92 1.1× 19 989
Elin Lindhagen Sweden 14 245 0.5× 138 0.7× 50 0.3× 89 0.9× 16 0.2× 28 505
Lawrence MacPherson United States 13 510 1.0× 301 1.5× 173 0.9× 86 0.9× 34 0.4× 21 868
Weiqiong Zuo China 14 316 0.6× 78 0.4× 181 1.0× 44 0.4× 44 0.5× 21 522
Joel Goldberg United States 18 665 1.3× 186 0.9× 516 2.8× 46 0.5× 31 0.4× 25 1.1k
Vincent Galullo United States 10 468 0.9× 182 0.9× 229 1.2× 22 0.2× 26 0.3× 10 724
Jonathan L. Doty United States 8 315 0.6× 78 0.4× 172 0.9× 17 0.2× 20 0.2× 11 563
David Y. Bouffard Canada 12 437 0.9× 194 0.9× 177 0.9× 72 0.7× 35 0.4× 17 743
Hiroshi Nara Japan 16 868 1.7× 378 1.8× 90 0.5× 292 3.0× 17 0.2× 26 1.0k

Countries citing papers authored by Andrew B. Benowitz

Since Specialization
Citations

This map shows the geographic impact of Andrew B. Benowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew B. Benowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew B. Benowitz more than expected).

Fields of papers citing papers by Andrew B. Benowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew B. Benowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew B. Benowitz. The network helps show where Andrew B. Benowitz may publish in the future.

Co-authorship network of co-authors of Andrew B. Benowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew B. Benowitz. A scholar is included among the top collaborators of Andrew B. Benowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew B. Benowitz. Andrew B. Benowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jurewicz, Anthony J., Kwok-Ho Chan, Markus A. Queisser, et al.. (2026). Identification of an allosteric site on the E3 ligase adapter cereblon. Nature. 651(8105). 482–490.
2.
Stacey, Peter, Xiao Qing Lewell, Agnieszka Konopacka, et al.. (2021). A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications. SLAS DISCOVERY. 26(7). 885–895. 5 indexed citations
3.
Law, Robert P., João Nunes, Chun‐wa Chung, et al.. (2021). Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs. Angewandte Chemie International Edition. 60(43). 23327–23334. 85 indexed citations
4.
Law, Robert P., João Nunes, Chun‐wa Chung, et al.. (2021). Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs. Angewandte Chemie. 133(43). 23515–23522. 4 indexed citations
5.
Schneider, Melanie, Chris J. Radoux, David Ochoa, et al.. (2021). The PROTACtable genome. Nature Reviews Drug Discovery. 20(10). 789–797. 162 indexed citations
6.
Chung, Chun‐wa, Han Dai, Esther Fernández, et al.. (2020). Structural Insights into PROTAC-Mediated Degradation of Bcl-xL. ACS Chemical Biology. 15(9). 2316–2323. 67 indexed citations
7.
Anderson, Niall A., et al.. (2020). Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs. Bioorganic & Medicinal Chemistry Letters. 30(9). 127106–127106. 50 indexed citations
8.
Benowitz, Andrew B., Katherine L. Jones, & John D. Harling. (2020). The therapeutic potential of PROTACs. Expert Opinion on Therapeutic Patents. 31(1). 1–24. 36 indexed citations
9.
Spletstoser, Jared T., Andrew B. Benowitz, Nino Campobasso, et al.. (2019). Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections. Bioorganic & Medicinal Chemistry Letters. 29(16). 2410–2414. 5 indexed citations
10.
Zeng, Xin, Robert B. Kirkpatrick, Glenn A. Hofmann, et al.. (2018). Screen for modulators of atonal homolog 1 gene expression using notch pathway-relevant gene transcription based cellular assays. PLoS ONE. 13(12). e0207140–e0207140. 5 indexed citations
11.
Benowitz, Andrew B., H. Christian Eberl, Connie L. Erickson‐Miller, et al.. (2018). A hit deconstruction approach for the discovery of fetal hemoglobin inducers. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3676–3680. 11 indexed citations
12.
Li, Hu, Wensheng Xie, Elizabeth R. Gore, et al.. (2013). Development of Phenotypic Screening Assays for γ-Globin Induction Using Primary Human Bone Marrow Day 7 Erythroid Progenitor Cells. SLAS DISCOVERY. 18(10). 1212–1222. 9 indexed citations
13.
Howard, Steven, Nader Amin, Andrew B. Benowitz, et al.. (2013). Fragment-Based Discovery of 6-Azaindazoles As Inhibitors of Bacterial DNA Ligase. ACS Medicinal Chemistry Letters. 4(12). 1208–1212. 20 indexed citations
14.
Benowitz, Andrew B., David Payne, & Jennifer L. Hoover. (2010). Antibacterial Drug Discovery in the Age of Resistance. Microbe Magazine. 5(9). 390–396. 4 indexed citations
15.
Song, Fengbin, Steve Fidanze, Andrew B. Benowitz, & Yoshito Kishi. (2007). Total synthesis of mycolactones A and B. Tetrahedron. 63(26). 5739–5753. 27 indexed citations
16.
Song, Fengbin, Steve Fidanze, Andrew B. Benowitz, & Yoshito Kishi. (2002). Total Synthesis of the Mycolactones. Organic Letters. 4(4). 647–650. 55 indexed citations
17.
Benowitz, Andrew B., Steve Fidanze, Pamela L. C. Small, & Yoshito Kishi. (2001). Stereochemistry of the Core Structure of the Mycolactones. Journal of the American Chemical Society. 123(21). 5128–5129. 70 indexed citations
18.
Lee, Kon Ho, Gary L. Olson, David Bolin, et al.. (2000). The Crystal Structure of a Pyrrolinone−Peptide Hybrid Ligand Bound to the Human Class II MHC Protein HLA-DR1. Journal of the American Chemical Society. 122(35). 8370–8375. 12 indexed citations
19.
Smith, Amos B., Andrew B. Benowitz, Paul A. Sprengeler, et al.. (1999). Design and Synthesis of a Competent Pyrrolinone−Peptide Hybrid Ligand for the Class II Major Histocompatibility Complex Protein HLA-DR1. Journal of the American Chemical Society. 121(40). 9286–9298. 37 indexed citations
20.
Smith, Amos B., Andrew B. Benowitz, David A. Favor, Paul A. Sprengeler, & Ralph Hirschmann. (1997). A second-generation synthesis of scalemic 3,5,5-trisubstituted pyrrolin-4-ones: Incorporation of functionalized amino acid side-chains. Tetrahedron Letters. 38(22). 3809–3812. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörg Trappe Breakdown of academic impact, for papers by Benjamin P. Martin Breakdown of academic impact, for papers by Elin Lindhagen Breakdown of academic impact, for papers by Lawrence MacPherson Breakdown of academic impact, for papers by Weiqiong Zuo Breakdown of academic impact, for papers by Joel Goldberg Breakdown of academic impact, for papers by Vincent Galullo Breakdown of academic impact, for papers by Jonathan L. Doty Breakdown of academic impact, for papers by David Y. Bouffard Breakdown of academic impact, for papers by Hiroshi Nara
Rankless by CCL
2026